Indicators of Homologous Recombination Deficiency in Breast Cancer and Association with Response to Neoadjuvant Chemotherapy

被引：0
|
作者：
Lips, E. H.
Mulder, L.
Hannemann, J.
Laddach, N.
Vrancken-Peeters, M-J F. T. D.
van de Vijver, M. J.
Wesseling, J.
Nederlof, P. M.
Rodenhuis, S.
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] MRC Holland, Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-PD07-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD07-07
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy
    Lips, E. H.
    Mulder, L.
    Hannemann, J.
    Laddach, N.
    Peeters, M. T. F. D. Vrancken
    van de Vijver, M. J.
    Wesseling, J.
    Nederlof, P. M.
    Rodenhuis, S.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (04) : 870 - 876
  • [2] Homologous recombination deficiency in breast cancer and association with response to neo-adjuvant chemotherapy
    Lips, E. H.
    Mulder, L.
    Hannemann, J.
    Peeters, M. J. Vrancken
    van de Vijver, M. J.
    Wesseling, J.
    Nederlof, P. M.
    Rodenhuis, S.
    [J]. EJC SUPPLEMENTS, 2010, 8 (03): : 60 - 61
  • [3] Determining homologous recombination deficiency scores with whole exome sequencing and their association with responses to neoadjuvant chemotherapy in breast cancer
    Kim, Seung Jin
    Sota, Yoshiaki
    Naoi, Yasuto
    Honma, Keiichiro
    Kagara, Naofumi
    Miyake, Tomohiro
    Shimoda, Masafumi
    Tanei, Tomonori
    Seno, Shigeto
    Matsuda, Hideo
    Noguchi, Shinzaburo
    Shimazu, Kenzo
    [J]. TRANSLATIONAL ONCOLOGY, 2021, 14 (02):
  • [4] Homologous recombination deficiency (HRD) assay predicts response to cisplatin neoadjuvant chemotherapy in patients with triple negative breast cancer
    Richardson, Andrea L.
    Silver, Daniel P.
    Szallasi, Zoltan
    Birkbak, Nicolai J.
    Wang, Zhigang C.
    Iglehart, J. Dirk
    Mayer, Erica L.
    Winer, Eric P.
    Tung, Nadine M.
    Ryan, Paula D.
    Isakoff, Steven J.
    Barry, William T.
    Greene-Collozi, April
    Gutin, Alexander
    Reid, Julia
    Neff, Chris
    Jones, Joshua
    Timms, Kirsten
    Hartman, Anne-Renee
    Garber, Judy E.
    [J]. CANCER RESEARCH, 2015, 75
  • [5] A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
    Graeser, Monika
    McCarthy, Afshan
    Lord, Christopher J.
    Savage, Kay
    Hills, Margaret
    Salter, Janine
    Orr, Nicholas
    Parton, Marina
    Smith, Ian E.
    Reis-Filho, Jorge S.
    Dowsett, Mitch
    Ashworth, Alan
    Turner, Nicholas C.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (24) : 6159 - 6168
  • [6] Homologous recombination deficiency in breast cancer
    Thomas Bartl
    Alex Farr
    [J]. memo - Magazine of European Medical Oncology, 2020, 13 : 375 - 379
  • [7] Homologous recombination deficiency in breast cancer
    Bartl, Thomas
    Farr, Alex
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (04) : 375 - 379
  • [8] Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
    Telli, Melinda L.
    Timms, Kirsten M.
    Reid, Julia
    Hennessy, Bryan
    Mills, Gordon B.
    Jensen, Kristin C.
    Szallasi, Zoltan
    Barry, William T.
    Winer, Eric P.
    Tung, NadineM.
    Isakoff, Steven J.
    Ryan, Paula D.
    Greene-Colozzi, April
    Gutin, Alexander
    Sangale, Zaina
    Iliev, Diana
    Neff, Chris
    Abkevich, Victor
    Jones, Joshua T.
    Lanchbury, Jerry S.
    Hartman, Anne-Renee
    Garber, Judy E.
    Ford, James M.
    Silver, Daniel P.
    Richardson, Andrea L.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3764 - 3773
  • [9] Immune microenvironment, homologous recombination deficiency and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: JBCRG22 TR
    Ueno, T.
    Kitano, S.
    Masuda, N.
    Ikarashi, D.
    Yamashita, M.
    Kadoya, T.
    Bando, H.
    Yamanaka, T.
    Ohtani, S.
    Nagai, S.
    Nakayama, T.
    Takahashi, M.
    Saji, S.
    Aogi, K.
    Velaga, R. M.
    Kawaguchi, K.
    Morita, S.
    Haga, H.
    Ohno, S.
    Toi, M.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1217 - S1218
  • [10] Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR
    Takayuki Ueno
    Shigehisa Kitano
    Norikazu Masuda
    Daiki Ikarashi
    Makiko Yamashita
    Tomohiro Chiba
    Takayuki Kadoya
    Hiroko Bando
    Takashi Yamanaka
    Shoichiro Ohtani
    Shigenori Nagai
    Takahiro Nakayama
    Masato Takahashi
    Shigehira Saji
    Kenjiro Aogi
    Ravi Velaga
    Kosuke Kawaguchi
    Satoshi Morita
    Hironori Haga
    Shinji Ohno
    Masakazu Toi
    [J]. BMC Medicine, 20
12345